Skip to main content
Clinical Trials/NCT04385147
NCT04385147CompletedNot Applicable

The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study

Al-Azhar University5 sites in 5 countries670 target enrollmentStarted: May 18, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
670
Locations
5
Primary Endpoint
Age, gender, nationality

Study Overview

Brief Summary

In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.

Detailed Description

In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.

evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit.

Target audience:

  • Physicians performing advanced gastrointestinal endoscopies in different countries.

Objectives:

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients referred for ERCP or EUS during the study period

Exclusion Criteria

  • Patients refusing to participate in the study

Outcomes

Primary Outcomes

Age, gender, nationality

Time Frame: 3 months

Investigators will report the baseline demographic data (age, gender, nationality) of all patients.

procedure related complications

Time Frame: 3 months

Investigators will report the procedure related complications.

Indication for procedure, status of SARS-CoV-2 infection

Time Frame: 3 months

Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.

Complete blood count and liver functions tests

Time Frame: 3 months

Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.

Secondary Outcomes

  • Effect of COVID-19 precautions on staff number(3 months)
  • Effect of COVID-19 precautions on procedure time(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Alboraie

Lecturer of medicine and gastroenterology

Al-Azhar University

Study Sites (5)

Loading locations...

Similar Trials